Table 6.
Types of LTP treatment used in HAE type I/II compared to HAE nC1-INH.
| HAE type I/II (n = 17), n (%) | HAE nC1-INH (n = 15), n (%) | |
|---|---|---|
| Treatment(s) you have received as LTP | ||
| Tranexamic acid | 3 (18%) | 9 (60%) |
| SC C1-INH concentrate | 9 (53%) | 3 (20%) |
| IV C1-INH concentrate | 7 (41%) | 3 (20%) |
| Other | 3 (18%) | 0 (0%) |
C1-INH, C1 inhibitor; HAE, hereditary angioedema; HAE nC1-INH, hereditary angioedema with normal C1 inhibitor; IV, intravenous; LTP, long-term prophylaxis; SC, subcutaneous.